Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Background Pulmonary hypertension (PH) complicating systemic sclerosis (SSc)-related interstitial lung disease (ILD) is usually associated with a poor prognosis. However, data are either lacking or scarce on prognostic factors in this condition. The objectives of this study were to compare the survival of patients with ILD-associated PH (PH-ILD) or pulmonary arterial hypertension (PAH) and to determine whether the severity of PH has prognostic value in SSc-associated PH-ILD.Methods Consecutive patients with SSc and PH-ILD (n = 47) or PAH (n = 50) confirmed by right-sided heart catheterization were included in a cross-sectional analysis. PH was classified as mild (mean pulmonary arterial pressure [mPAP] ≤ 35 mm Hg) or moderate to severe (mPAP > 35 mm Hg).Results As compared with patients with PAH, subjects with PH-ILD were younger, were more frequently men with a history of smoking, had more frequently diffuse SSc, less frequently anticentromere antibodies, and a lower FVC/diffusing capacity of lung for carbon monoxide (DLCO) ratio. They had a worse prognosis than patients with PAH (3-year survival of 47% vs 71%, respectively; P = .07). Patients with mild PH-ILD had similar poor outcomes when compared with those with moderate to severe PH-ILD. Pericardial effusion (hazard ratio [HR], 2.44; P = .04) and lower DLCO (HR, 0.96; P = .01) were the only independent factors predictive of a poor survival in the PH-ILD group.Conclusions Patients with SSc with PH-ILD had a different phenotype and a worse prognosis than those with SSc and PAH. Lower DLCO and presence of pericardial effusion were predictive of a poor outcome in PH-ILD, whereas mPAP seemed to have no prognostic significance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other high-risk profiles include familial PAH, PVOD, CTD-PAH, CTD-PAH associated with concomitant ILD, rapidly progressive disease despite therapy, and development of hemoptysis.(282, 291–293)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [292]
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System
Goh, N. S. L., Desai, S. R., Veeraraghavan, S., Hansell, D. M., Copley, S. J., Maher, T. M., Corte, T. J., Sander, C. R., Ratoff, J., Devaraj, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-877oc · Cited by 1,230
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Standardization of the measurement of transfer factor (diffusing capacity)
Cotes, J. E., Chinn, D. J., Quanjer, P. H., Roca, J., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.041s1693 · Cited by 680
Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Condliffe, R., Kiely, D. G., Peacock, A. J., Corris, P. A., Gibbs, J. S. R., Vrapi, F., Das, C., Elliot, C. A., Johnson, M., DeSoyza, J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-953oc · Cited by 657
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Management of interstitial lung disease associated with connective tissue disease
Mathai, S. C., & Danoff, S. K. (2016) · BMJ · doi:10.1136/bmj.h6819 · Cited by 328
Lefèvre, G., Dauchet, L., Hachulla, E., Montani, D., Sobanski, V., Lambert, M., Hatron, P., Humbert, M., & Launay, D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38029 · Cited by 274
Self-citationPredictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease
Winstone, T. A., Assayag, D., Wilcox, P. G., Dunne, J. V., Hague, C. J., Leipsic, J., Collard, H. R., & Ryerson, C. J. (2014) · Chest · doi:10.1378/chest.13-2626 · Cited by 249
Launay, D., Sitbon, O., Hachulla, E., Mouthon, L., Gressin, V., Rottat, L., Clerson, P., Cordier, J.-F., Simonneau, G., & Humbert, M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202489 · Cited by 168
Self-citationConnective tissue disease-associated pulmonary arterial hypertension in Chinese patients
Hao, Y.-J., Jiang, X., Zhou, W., Wang, Y., Gao, L., Wang, Y., Li, G.-T., Hong, T., Huo, Y., Jing, Z.-C., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00182813 · Cited by 160
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival
Hervier, B., Meyer, A., Dieval, C., Uzunhan, Y., Devilliers, H., Launay, D., Canuet, M., Tetu, L., Agard, C., Sibilia, J., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00156312 · Cited by 160
Self-citationGunnarsson, R., Molberg, Ø., Gilboe, I., & Gran, J. T. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143792 · Cited by 154
Pulmonary hypertension in chronic interstitial lung diseases
Caminati, A., Cassandro, R., & Harari, S. A. (2013) · European Respiratory Review · doi:10.1183/09059180.00002713 · Cited by 129
Disease-related autoantibody profile in patients with systemic sclerosis
Liaskos, C., Μάρου, Ε., Simopoulou, T., Barmakoudi, M., Efthymiou, G., Scheper, T., Meyer, W., Bogdanos, D. P., & Sakkas, L. I. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1357699 · Cited by 116
Jilwan, F. N., Escourrou, P., Garcia, G., Jaïs, X., Humbert, M., & Roisman, G. (2013) · Chest · doi:10.1378/chest.11-3124 · Cited by 115
Self-citationAntoniou, K. M., Margaritopoulos, G. A., Goh, N. S. L., Karagiannis, K., Desai, S. R., Nicholson, A. G., Siafakas, N. M., Coghlan, G., Denton, C. P., Hansell, D. M., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39528 · Cited by 111
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus
Johnson, S. R., & Granton, J. T. (2011) · European Respiratory Review · doi:10.1183/09059180.00003811 · Cited by 100
Shirai, Y., Yasuoka, H., Okano, Y., Takeuchi, T., Satoh, T., & Kuwana, M. (2012) · Rheumatology · doi:10.1093/rheumatology/kes140 · Cited by 97
Pulmonary hypertension phenotypes in patients with systemic sclerosis
Haque, A., Kiely, D. G., Kovács, G., Thompson, A. A. R., & Condliffe, R. A. (2021) · European Respiratory Review · doi:10.1183/16000617.0053-2021 · Cited by 93
Gunnarsson, R., Andreassen, A. K., Molberg, Ø., Lexberg, Å. S., Time, K., Dhainaut, A., Bertelsen, L.-T., Palm, Ø., Irgens, K., Becker-Merok, A., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/kes430 · Cited by 86
Young, A., Vummidi, D., Visovatti, S., Homer, K., Wilhalme, H., White, E. S., Flaherty, K., McLaughlin, V., & Khanna, D. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40862 · Cited by 85
Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease
Morisset, J., Vittinghoff, E., Elicker, B. M., Hu, X., Le, S., Ryu, J. H., Jones, K. D., Haemel, A., Golden, J. A., Boin, F., et al. (2017) · Chest · doi:10.1016/j.chest.2017.06.009 · Cited by 77
Khanna, D., Zhao, C., Saggar, R., Mathai, S. C., Chung, L. S., Coghlan, G., Shah, M., Hartney, J. M., & McLaughlin, V. V. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41669 · Cited by 74
Chauvelot, L., Gamondes, D., Berthiller, J., Nieves, A., Renard, S., Catella, J., Ahmad, K., Bertoletti, L., Camara, B., Gomez, E., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41512 · Cited by 68
Self-citationHoffmann‐Vold, A., Molberg, Ø., Midtvedt, Ø., Garen, T., & Gran, J. T. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121390 · Cited by 65
Launay, D., Savale, L., BEREZNE, A., Pavec, J. L., HACHULLA, E., Mouthon, L., Sitbon, O., Lambert, B., Gaudric, M., Jaïs, X., et al. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.01.020 · Cited by 61
Self-citationDeterminants of exercise-induced pulmonary arterial hypertension in systemic sclerosis
Voilliot, D., Magné, J., Dulgheru, R., Kou, S., Henri, C., Laaraibi, S., Sprynger, M. G., André, B., Piérard, L., & Lancellotti, P. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.02.042 · Cited by 60
Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis
Vandecasteele, E. H., Pauw, M. D., Keyser, F. D., Decuman, S., Deschepper, E., Piette, Y., Brusselle, G., & Smith, V. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.084 · Cited by 59
Nunes, J. P. L., Cunha, A., Meirinhos, T., Nunes, A., Araújo, P. M., Godinho, A. R., Vilela, E., & Vaz, C. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.06.009 · Cited by 58
Fröhlich, G., Keller, P., Schmid, F. A., Wolfrum, M., Osranek, M., Falk, C., Noll, G., Enseleit, F., Reinthaler, M., Meier, P., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht006 · Cited by 57
Volkmann, E. R., Saggar, R., Khanna, D., Torres, B., Flora, A. S., Yoder, L., Clements, P. J., Elashoff, R. M., Ross, D. J., Agrawal, H., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38623 · Cited by 50
Interstitial Lung Disease in Systemic Sclerosis
Weir, N. A., & Steen, V. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0770-0_4 · Cited by 48
Systemic sclerosis—challenges for clinical practice
McMahan, Z. H., & Hummers, L. K. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.191 · Cited by 45
Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis
Ewert, R., Ittermann, T., Habedank, D., Held, M., Lange, T. J., Halank, M., Winkler, J., Gläser, S., Olschewski, H., & Kovács, G. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-1003-7 · Cited by 40
Batal, O., Dardari, Z., Costabile, C., Gorcsan, J., Arena, V. C., & Mathier, M. A. (2015) · Echocardiography · doi:10.1111/echo.12909 · Cited by 38
The Clinical Relevance of Antifibrillarin (anti‐U3‐ RNP ) Autoantibodies in Systemic Sclerosis
Tall, F., Dechomet, M., Rivière, S., Cottin, V., Ballot, E., TIEV, K. P., Montin, R., Morin, C., Chantran, Y., Grangé, C., et al. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12510 · Cited by 37
Self-citationHjalmarsson, C., Kjellström, B., Jansson, K., Nisell, M., Kylhammar, D., Kavianipour, M., Rådegran, G., Söderberg, S., Wikström, G., Wuttge, D. M., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00854-2020 · Cited by 34
Hsu, V. M., Chung, L. S., Hummers, L. K., Shah, A. A., Simms, R. W., Bolster, M. B., Hant, F. N., Silver, R. M., Fischer, A., Hinchcliff, M., et al. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.180018 · Cited by 34
Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
Lota, H., & Renzoni, E. A. (2012) · International Journal of Rheumatology · doi:10.1155/2012/121439 · Cited by 32
Recent advances in connective tissue disease related interstitial lung disease
Suzuki, A., Kondoh, Y., & Fischer, A. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1335600 · Cited by 30
Sanges, S., Guerrier, T., Duhamel, A., Guilbert, L., Hauspie, C., Largy, A., Balden, M., Podevin, C., Lefèvre, G., Jendoubi, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954007 · Cited by 27
Self-citationFairley, J. L., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G., Walker, J. G., Host, L., Morrisroe, K., Apostolopoulous, D., et al. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03059-x · Cited by 27
Troponin I and echocardiography in patients with systemic sclerosis and matched population controls
Nordin, A., Svenungsson, E., Björnådal, L., Elvin, K., Larsson, A. O., & Jensen‐Urstad, K. (2016) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2016.1192217 · Cited by 27
Sanges, S., Jendoubi, M., Kavian, N., Hauspie, C., Speca, S., Crave, J., Guerrier, T., Lefèvre, G., Sobanski, V., Savina, A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00053 · Cited by 26
Self-citationNoviani, M., Saffari, S. E., Tan, J. L., Yip, J. W. L., Teng, G. G., Law, W. G., Chan, G. Y. L., Santosa, A., Lim, A. Y. N., Hong, C., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.11.005 · Cited by 26
Almoallim, H. M., & Cheikh, M. (2021) · Springer eBooks · doi:10.1007/978-981-15-8323-0 · Cited by 25
Pulmonary Hypertension Associated with Connective Tissue Disease
Mathai, S. C. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.08.003 · Cited by 24
HACHULLA, E., Launay, D., Boucly, A., Mouthon, L., de Groote, P., Cottin, V., Pugnet, G., Prévôt, G., Bourlier, D., Dauphin, C., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.10.045 · Cited by 24
Self-citationGlycoprotein 130 Inhibitor Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
Huang, Z., Liu, Z., Luo, Q., Zhao, Z., Zhao, Q., Zheng, Y., Xi, Q., & Tang, Y. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.058 · Cited by 22
Erdoğan, M., Avcı, B. K., Ebren, C., Ersoy, Y., Öngen, Z., Öngen, G., Hamuryudan, V., & Hatemi, G. (2023) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/gzo4r2 · Cited by 20
Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography
Zompatori, M., Leone, M. B., Giannotta, M., Galiè, N., Palazzini, M., Reggiani, M. L. B., Bono, L., & Pollini, G. S. (2013) · La radiologia medica · doi:10.1007/s11547-013-0934-1 · Cited by 19
Smith, H. D., Thompson, A. A. R., Akil, M., Alabed, S., Charalampopoulos, A. F., Dwivedi, K., Elliot, C. A., Hameed, A. G., Haque, A., Hamilton, N., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.06.007 · Cited by 19
Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
Glynn, P. A., Hale, S. L., Hussain, T., & Freed, B. H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.846213 · Cited by 18
Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course
Becker, M. O., & Riemekasten, G. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2016.1115717 · Cited by 18
Gopal, D. M., Doldt, B., Finch, K., Simms, R. W., Farber, H. W., & Gokce, N. (2014) · Arthritis Care & Research · doi:10.1002/acr.22307 · Cited by 16
Lung Disease in Rheumatic Disorders
Kelly, C. A. (2019) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.30.3.147 · Cited by 14
Interstitial Lung Disease: The Initial Approach
Alhamad, E. H., & Cosgrove, G. P. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.08.008 · Cited by 14
Tangri, V., Hewson, C., Baron, M. G., Bonner, A., Fritzler, M. J., & Pope, J. E. (2013) · Open Journal of Rheumatology and Autoimmune Diseases · doi:10.4236/ojra.2013.32017 · Cited by 14
Ratanawatkul, P., Solomon, J. J., Kim, D., George, M. P., McGibbon, L. R. M., Demoruelle, M. K., Maleki-Fischbach, M., Amigues, I., Kastsianok, L., & Pérez, E. R. F. (2020) · ERJ Open Research · doi:10.1183/23120541.00309-2019 · Cited by 13
Gleason, J. B., Patel, K., Hernandez, F., Hadeh, A., Highland, K. B., Rahaghi, F., & Mehta, J. P. (2017) · Lung · doi:10.1007/s00408-017-0005-6 · Cited by 13
Luo, Y., Gordon, J., Xu, J. C., Kolstad, K. D., Chung, L. S., Steen, V. D., Bernstein, E. J., PHAROS Investigators, Csuka, M. E., Derk, C. T., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead368 · Cited by 12
La patología pulmonar asociada a las enfermedades del tejido conectivo
Marfá, R. Y., Ysamat, A. B., Pérez, S. E., Negredo, M. B., & Molina, R. R. (2012) · Radiología · doi:10.1016/j.rx.2012.03.004 · Cited by 10
George, P. M., & Wells, A. U. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1427064 · Cited by 9
Group 3 Pulmonary Hypertension
Shioleno, A., & Ruopp, N. F. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.11.006 · Cited by 9
Pulmonary Manifestations of Connective Tissue Diseases
Taha, R., & Feteih, M. N. (2021) · Springer eBooks · doi:10.1007/978-981-15-8323-0_7 · Cited by 9
Sherif, A. A., Gilvaz, V. J., Abraham, S., Saji, A. M., Mathew, D., Isath, A. M., Rajendran, A., Contreras, J., Lanier, G. M., & Reginato, A. M. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14457 · Cited by 9
Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis
Gargani, L., Voilliot, D., D’Alto, M., Ágoston, G., Moreo, A. M., Serra, W., Pieri, F., Mori, F., Wierzbowska-Drabik, K. A., Matucci‐Cerinic, M., et al. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.02.004 · Cited by 9
Pulmonary Hypertension Complicating Connective Tissue Disease
Belperio, J. A., Saggar, R., Fishbein, M. C., Saggar, R., & Lynch, J. P. (2013) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0033-1356547 · Cited by 8
Pulmonary hypertension in patients with interstitial pneumonia with autoimmune features
Alzghoul, B. N., Hamburger, R. F., Lewandowski, T. J., Janssen, B., Grey, D., Xue, W., Ataya, A., Alnuaimat, H., Gomez-Manjarres, D. C., Patel, D. C., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020944117 · Cited by 8
Biomarker discovery in systemic sclerosis: state of the art
Bonella, F., Patuzzo, G., & Lunardi, C. (2015) · Current Biomarker Findings · doi:10.2147/cbf.s60446 · Cited by 6
Gkouvi, A., Boutel, M., Zioga, N., Pagkopoulou, E., Mytilinaiou, M. G., Rampiadou, C., Margaritopoulos, G. A., Bogdanos, D. P., Dimitroulas, T., & Simopoulou, T. (2025) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.080825.lfh · Cited by 6
Sanges, S., Sobanski, V., Lamblin, N., HACHULLA, E., Savale, L., Montani, D., & Launay, D. (2023) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2023.10.450 · Cited by 6
Self-citationLung disease associated with connective tissue disease
Marfá, R. Y., Ysamat, A. B., Pérez, S. E., Negredo, M. B., & Molina, R. R. (2013) · Radiología (English Edition) · doi:10.1016/j.rxeng.2012.03.001 · Cited by 6
Lung Transplantation for Connective Tissue Disease-Associated Lung Disease
Hadley, R. J., & Chan, K. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0770-0_13 · Cited by 4
Zhang, H., & xiaoyan, X. L. (2020) · Aktuelle Rheumatologie · doi:10.1055/a-1135-8548 · Cited by 4
Clinical assessment for pulmonary hypertension in interstitial lung disease
Chan, R. K., Horrigan, M., Goh, N. S. L., & Khor, Y. H. (2022) · Internal Medicine Journal · doi:10.1111/imj.15887 · Cited by 4
Jose, A., Delio, J., Gwizdala, J., Goulart, H. E., & Ahari, J. (2018) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v35i4.6855 · Cited by 4
Lung Transplantation in Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
Lyu, D. M., & Chan, K. M. (2018) · Current Pulmonology Reports · doi:10.1007/s13665-018-0207-2 · Cited by 3
Pulmonary Hypertension Associated with Connective Tissue Disease
Mathai, S. C., & Hummers, L. K. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0770-0_11 · Cited by 3
Pathology of Systemic Sclerosis
Rooper, L. M., & Askin, F. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_12 · Cited by 3
Pulmonary hypertension in systemic sclerosis with usual interstitial pneumonia
Carbone, R. G., Monselise, A., Barisione, E., Fontana, V., Paredi, P., & Puppo, F. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03267-y · Cited by 3
A 50-Year-Old Woman With Limited Scleroderma Presenting With Shortness of Breath
Walia, A., Singh, I., Ryu, C., & Lutchmansingh, D. D. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.041 · Cited by 2
Hassoun, P. M., & Shafiq, M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38031 · Cited by 2
Beale, A. L., Safavi, S., & Granton, J. T. (2024) · Current Respiratory Medicine Reviews · doi:10.2174/011573398x269419231213095516 · Cited by 1
Coleman, D. M. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_163 · Cited by 1
The Management of Pulmonary Arterial Hypertension in the Setting of Systemic Sclerosis
Mathai, S. C., & Sitbon, O. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_29 · Cited by 1
Pathology of Systemic Sclerosis
Rooper, L. M., & Askin, F. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_13 · Cited by 1
Pathogenetic features of pulmonary hypertension in systemic sclerosis
Vasenina, V. S., Александровна, Д. Н., Александрович, К. А., Andriyashkina, D. Y., & Клименко, А. А. (2025) · The Clinician · doi:10.17650/1818-8338-2025-19-1-k740 · Cited by 1
Hao, Y., Thakkar, Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., Youssef, P. P., Gabbay, E., Roddy, J., Walker, J., et al. (2014) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.1186/s13075-015-0517-5 · Cited by 1
Ferber-Viart, C., Couraud, S., Gormand, F., & Pachéco, Y. (2013) · Physiology Journal · doi:10.1155/2013/539076 · Cited by 1
Ágoston, G. (2015) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2575
Pathology of Vascular Changes in Interstitial Lung Diseases
Nunès, H., Dorfmüller, P., Uzunhan, Y., Valeyre, D., Bernaudin, J., & Kambouchner, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-49918-5_3
Pulmonary Hypertension in Idiopathic Interstitial Pneumonias
Bax, S., Wells, A. U., Price, L. C., & Wort, S. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-49918-5_6
Pulmonary Hypertension Associated with Respiratory Diseases
Kolb, T. M., & Hassoun, P. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_207-1
Pulmonary Hypertension Associated with Respiratory Disease
Kolb, T. M., & Hassoun, P. M. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_207
Marqueurs pronostiques et stratification du risque dans l’HTAP
Boucly, A. (2021) · theses.fr (ABES) · doi:10.70675/5ed4fe2cz1e57z41c5zac6az4af0eec45aa6
The Management of Pulmonary Arterial Hypertension in the Setting of Systemic Sclerosis
Mathai, S. C., & Galiè, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_28
Yehudіna, Y. D., & Kalashnykova, O. S. (2018) · Medicni perspektivi · doi:10.26641/2307-0404.2018.3.147959
Diagnosis and prognosis in connective tissue disease associated pulmonary hypertension
Schreiber, B. E., & Schreiber, E. (2013) · UCL Discovery (University College London)
Mixed connective tissue disease: Results from a nation-wide multicenter survey of Norwegian patients
Gunnarsson, R. (2013) · NVA (Nasjonalt vitenarkiv)
Cottin, V. (2011) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2011.09.012
Self-citationPhénotypes dans la sclérodermie systémique : une analyse par clusters
Nowak, S. (2018) · HAL
Hipertensão pulmonar na esclerose sistêmica
Sampaio-Barros, P. D. (2014) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2014.13.2.24-27
Merger, M., Giovannelli, J., Launay, D., Lamblin, N., de Groote, P., Fertin, M. J., Bervar, J.-F., Valentin, V., Sobanski, V., HACHULLA, E., et al. (2026) · Arthritis Research & Therapy · doi:10.1186/s13075-026-03821-x
Self-citation
Metadata
- Authors
- Launay, D., Humbert, M., Berezne, A., Cottin, V., Allanore, Y., Couderc, L.-J., Bletry, O., Yaici, A., Hatron, P.-Y., Mouthon, L., Le Pavec, J., Clerson, P., & Hachulla, E.
- Affiliations
- Université de Lille (FR)
- Université Paris-Sud (FR)
- Hôpital Cochin (FR)
- Lyon 1 Université (FR)
- Hôpital Foch (FR)
- Corresponding author
- Launay, David
- ORCID
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 140
- Issue
- 4
- Pages
- 1016-1024
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2130932769
- Cited by
- 99
- References
- 40
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 11 · 2013: 15 · 2012: 5
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- systemic sclerosis, pulmonary hypertension, interstitial lung disease, pulmonary arterial hypertension, survival, prognostic factors, pericardial effusion, diffusing capacity for carbon monoxide, mean pulmonary artery pressure, right heart catheterization
- MeSH terms
- Adult, Aged, Antibodies, Antinuclear, Blood Pressure, Carbon Monoxide, Cross-Sectional Studies, Female, Humans, Hypertension, Pulmonary, Lung, Male, Middle Aged, Predictive Value of Tests, Prognosis, Scleroderma, Systemic, Severity of Illness Index, Comorbidity, Survival Rate, Lung Diseases, Interstitial, Familial Primary Pulmonary Hypertension
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.